NEFL and Obesity: NfL levels may reflect specific pathology involving active axonal damage/degeneration early in the disease process well, but interpretation of higher levels are confounded later by comorbidities such as aging or obesity, consistent with the sensitivity of NfL for neuroaxonal damage but little specificity for any one MS-specific biological phenomenon (66).